Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanola

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514336, 5142228, 5142238, 5142315, 546321, 546284, 544131, C07D21186, A61K 31455

Patent

active

049944762

ABSTRACT:
A series of compounds useful in treating cardiovascular disorders due to the combined expression of both .beta.-block and calcium-block activity by these agents. This useful combination of actions is effected by a novel combination of structural subunits forming these compounds. Essentially, .beta.-blocking aryloxypropanolamine moieties are attached via their aryl ring or amino nitrogen at one of the carboxylate groups of calcium-blocking 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates. These compounds are prepared from new 4-aryl-1,4-dihydropyridine intermediate compounds.

REFERENCES:
patent: 3485847 (1969-12-01), Bossert et al.
patent: 4532248 (1985-07-01), Franckowink et al.
Baldwin et al., J. Med. Chem., 24, pp. 628-631 (1981).
Bossert, F. et al., "4-Aryldihydropyridine", Angew. Chem. Int. Ed. Engl. 20, (1981), pp. 762-769.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanola does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanola, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanola will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1143953

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.